Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 381-386, 2021.
Article in Chinese | WPRIM | ID: wpr-942444

ABSTRACT

Objective: To investigate the clinicopathological characteristics, treatment and prognosis of head and neck carcinosarcoma. Methods: The clinical data of 14 patients with head and neck carcinosarcoma treated in the First Affiliated Hospital of Zhengzhou University from January 2010 to May 2020 were retrospectively analyzed, including 11 males and 3 females, with age range from 30 to 72 years old. Clinicopathological characteristics, treatments and follow-up results of patients were evaluated. Kaplan-Meier method was used to estimate the cumulative survival rate. Results: Histopathological examination showed the co-existence of malignant epithelial and mesenchymal components in all cases. Immunohistochemical staining of 13 cases showed cytokeratin and epithelial membrane antigens were positively expressed in the epithelial areas, whereas vimentin was positive in the malignant mesenchymal tissue area. Among 14 cases, 5 cases were treated with surgery, 3 cases with surgery and radiotherapy, and 6 cases with surgery, radiotherapy and chemotherapy. The follow-up time was 2-81 months, with a median follow-up time of 22.5 months. Except for one patient who was lost to follow-up in 21 months after treatment, among the remaining 13 patients, 4 patients had recurrence, 8 patients died, and 5 patients had a tumor-free survival. The Kaplan-Meier analysis showed that the 1, 3, and 5-year cumulative survival rates of 14 patients with head and neck carcinosarcoma were 64.3%, 57.1%, and 42.9%, respectively. Conclusions: Carcinosarcoma of the head and neck is rare in clinic, histopathological and immunohistochemical examinations are important basis for diagnosis, and surgery is a preferred treatment. Carcinosarcoma of the head and neck has a poor prognosis, and patients should be followed up for a long time.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Carcinosarcoma/therapy , Kaplan-Meier Estimate , Neoplasm Recurrence, Local , Prognosis , Retrospective Studies
2.
Rev. otorrinolaringol. cir. cabeza cuello ; 68(3): 279-282, dic. 2008. ilus
Article in Spanish | LILACS | ID: lil-520468

ABSTRACT

Teratocarcinosarcoma rinosinusal es una neoplasia maligna infrecuente y rara, que combina elementos de teratoma y carcinosarcoma. Se compone de epitelio benigno o maligno (fibroblastos), mesénquima (cartílago, hueso o músculo liso) y elementos neurales. Hasta el año 2008 se han reportado un total de 63 casos de ubicación rinosinusal. Presentamos el caso de un teratocarcinosarcoma de fosa nasal, en un hombre de 67 años de edad, que consultó por obstrucción nasal rápidamente progresiva. La lesión se resecó completamente por abordaje endoscópico. El diagnóstico fue confirmado por histopatología e inmunohistoquímica. Se realizó tratamiento complementario con radioterapia, sin evidencia de recidiva al año después de la cirugía.


Rhinosinusal teratocarcinosarcoma is a rare malignant neoplasm, which combines teratoma and carcinoma elements. It is composed of benign or malignant epithelium (fibroblasts), mesenchymatic (cartilage, bone or smooth muscle) and neural elements. Until 2008, a total of 63 cases of rhinosinusal location have been reponed. We present the case of a nasal cavity teratocarcinosarcoma ín a 67 year old man that presented with rapidly progressing nasal obstruction. The lesion was completely resected by endoscopic approach. Diagnosis was confirmed by histological pathology and immunohistochemistry Additional treatment by radiotherapy was administered, with no evidence of recurrences a year after surgery.


Subject(s)
Humans , Male , Aged , Nose Neoplasms/pathology , Nose Neoplasms/therapy , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/therapy , Teratocarcinoma/pathology , Teratocarcinoma/therapy , Carcinosarcoma/pathology , Carcinosarcoma/therapy , Otorhinolaryngologic Surgical Procedures , Radiotherapy , Treatment Outcome , Tomography, X-Ray Computed
3.
Int. braz. j. urol ; 31(1): 10-16, Jan.-Feb. 2005. ilus, tab, graf
Article in English | LILACS | ID: lil-400091

ABSTRACT

INTRODUCTION: Renal cell carcinoma with sarcomatoid differentiation is a tumor with aggressive behavior that is poorly responsive to immunotherapy. The objective of this study is to report our experience in the treatment of 15 patients with this tumor. MATERIALS AND METHODS: We retrospectively analyzed 15 consecutive cases of renal cell carcinoma with sarcomatoid differentiation diagnosed between 1991 and 2003. The clinical presentation and the pathological stage were assessed, as were the tumor's pathological features, use of adjuvant immunotherapy and survival. The study's primary end-point was to assess survival of these individuals. RESULTS: The sample included 8 women and 7 men with mean age of 63 years (44 - 80); follow-up ranged from 1 to 100 months (mean 34). Upon presentation, 87 percent were symptomatic and 4 individuals had metastatic disease. Mean tumor size was 9.5 cm (4 - 24) with the following pathological stages: 7 percent pT1, 7 percent pT2, 33 percent pT3, and 53 percent pT4. The pathological features showed high-grade tumors with tumoral necrosis in 87 percent of the lesions and 80 percent of intratumoral microvascular invasion. Disease-free and cancer-specific survival rates were 40 and 46 percent respectively, with 2 cases responding to adjuvant immunotherapy. CONCLUSIONS: Patients with sarcomatoid tumors of the kidney have a low life expectancy, and sometimes surgical resection associated with immunotherapy can lead to a long-lasting therapeutic response.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma, Renal Cell/pathology , Carcinosarcoma/pathology , Kidney Neoplasms/pathology , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/therapy , Carcinosarcoma/mortality , Carcinosarcoma/therapy , Diagnosis, Differential , Disease-Free Survival , Follow-Up Studies , Immunotherapy/methods , Kidney Neoplasms/mortality , Kidney Neoplasms/therapy , Prognosis , Retrospective Studies , Survival Analysis , Survival Rate
4.
Rev. bras. mastologia ; 10(2): 93-6, jun. 2000.
Article in Portuguese | LILACS | ID: lil-278469

ABSTRACT

O carcinossarcoma constitui uma forma rara de tumor de mama, correspondendo a cerca de 0,2 por cento dos carcinomas de mama. Descreve-se um caso dessa variante neoplástica em uma mulher de 45 anos, atendida do Serviço de Ginecologia e Mama do Hospital Erasto Gaertner. Discutem-se também aspectos histológicos, bem como opçöes terapêuticas e fatores prognósticos dessa rara neoplasia


Subject(s)
Humans , Female , Adult , Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Carcinosarcoma/diagnosis , Carcinosarcoma/physiopathology , Carcinosarcoma/therapy , Mastectomy, Simple
5.
Rev. Cuerpo Méd ; 15(2): 15-6, 1996. ilus
Article in Spanish | LILACS | ID: lil-205775

ABSTRACT

En el presente trabajo se hace la presentación de un caso de carcinosarcoma localizado en el surco glosoepiglótico, único caso de la literatura nacional y el cuarto de la literatura mundial. Se presenta el caso con las manifestaciones clínicas referidas y el diagnóstico histopatológico efectuado. El tratamiento realizado fue la resección quirúrgica seguida de cobaltoterapia. El paciente evolucionó bien y está vivo y sin enfermedad 1 año y medio después


Subject(s)
Humans , Carcinosarcoma/diagnosis , Carcinosarcoma/therapy , Epiglottitis , Teratoma , Tongue Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL